The integration of data generated via high-throughput omic technologies
that describe different layers of biological complexity will enable the
identification of the next generation of biomarkers, therapeutic targets, and
molecular endpoints for clinical trials in food allergy. To that aim, tools from
systems biology, such as network modelling, will be invaluable to finding
solutions for the challenges posed by the integration of heterogeneous
biological data. GC, gas chromatography; LC, liquid chromatography; MS, mass
spectrometry; PBMC, peripheral blood mononuclear cell; SNP, single nucleotide
polymorphism; WES, whole exome sequencing; WGS, whole genome sequencing.